Compare Agilent Technologies Inc (A) vs Dow Inc (DOW) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs Dow Inc — how do they compare? Agilent Technologies Inc trades at $128.42 (market cap $37.04B), while Dow Inc trades at $29.3 (market cap $20.64B). The key difference: Agilent Technologies Inc is the larger of the two by market cap, and Dow Inc pays the higher dividend (4.89%). Which is the better fit depends on your goals.
| A | DOW | |
|---|---|---|
Market Cap | $37.04B | $20.64B |
Sector | Health | Basic Materials |
52-Week High | $157.20 | $41.87 |
52-Week Low | $110.24 | $20.65 |
Enterprise Value | $38.59B | $36.42B |
Dividend Yield | 0.78% | 4.89% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
DOW trades at $28.64, up 3.36% today, with a bearish technical signal despite recent earnings beats. The stock shows negative profitability with a net income margin of -7.24% and ROE of -17.85%, though valuation ratios like P/S of 0.5 appear modest. Cash flow trends indicate operational challenges, with 2025 operating cash flow at $1.03B down from prior years, while the company maintains a dividend payout.
Outlook remains cautious due to weak fundamentals and bearish technicals, but analyst consensus price target of $36.11 suggests 26% upside. Key risks include sustained negative margins and high debt levels, while potential catalysts hinge on cost-cutting effectiveness and market demand recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Dow Inc
Dow Inc is a diversified chemical manufacturing company. It combining science and technology to develop innovative solutions that are essential to human progress. Dow's portfolio is comprised of six global business units, organized into three operating segments: Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure, and Performance Materials & Coatings.
Read more on DOW →
